Home » Authors » Karen Young

Articles by Karen Young

CytRx, Global Genomics Merging In Deal Worth Up To $6.28M

Feb. 12, 2002

Inhibitex Closing $41M Round To Fund Product Development

Feb. 12, 2002

CytRx, Global Genomics Merging In Deal Worth Up To $6.28M

Feb. 12, 2002

Invenux Using RNA Technology To Discover Small Molecules

Feb. 11, 2002

Invenux Using RNA Technology To Discover Small Molecules

Feb. 11, 2002

Theratechnologies Partners Peptide In Japan With Sakai

Feb. 6, 2002

Aphton Raising $17.1M To Finance Clinical Programs

Feb. 6, 2002

Theratechnologies Partners Peptide In Japan With Sakai

Feb. 6, 2002

Aphton Raising $17.1M To Finance Clinical Programs

Feb. 6, 2002

CombinatoRx’s Approach Is Targeting Multiple Pathways

Feb. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...